Taking action for rare cancers
0
For many rare cancers patients, it can be difficult to have access to appropriate therapies and clinical expertise, due to the fact that there has been a limited number of clinical studies to find new drugs and treatments, writes Mihaela Militaru.
Mihaela Militaru is the director of the European Cancer Patient Coalition (ECPC).